Predicting embolic events in patients with nonvalvular atrial fibrillation: Evaluation of the CHADS2 score in a mediterranean population;Predicción de eventos embólicos en pacientes con fibrilación auricular no valvular: Evaluación del score CHADS 2 en una población mediterránea

Revista Espanola de Cardiologia

Volumn 61, Issue 1, 2008, Pages 29-35

  Ortiz, Martín Ruiz ^a,b   Romo, Elías ^a   Mesa, Dolores ^a   Delgado, Mónica ^a   Anguita, Manuel ^a   Granados, Amador López ^a   Castillo, Juan C ^a   Arizón, José M ^a   De Lezo, José Suárez ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b NONE   (Spain)

Author keywords

Atrial fibrillation; Prevention; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT;

AGED; ANEMIA; ANTICOAGULATION; ARTICLE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG CONTRAINDICATION; EMBOLISM; FEMALE; GERIATRIC PATIENT; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PREDICTION; PROSPECTIVE STUDY; SCORING SYSTEM; SOUTHERN EUROPE; SPAIN; STROKE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; AGE; FORECASTING; RISK ASSESSMENT;

AGE FACTORS; AGED; ATRIAL FIBRILLATION; DIABETES COMPLICATIONS; EMBOLISM; FEMALE; FORECASTING; HEART FAILURE; HUMANS; HYPERTENSION; MALE; PROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE;

EID: 41949101550     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13114954     Document Type: Article

References (15)

1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Europace. 2006;8:651-745.
2. Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation. Eur Heart J. 2001;22:1852-923.
3. Heras M, Fernández A, Gómez JA, Iriarte JA, Lidón RM. Guías de actuación clínica de la Sociedad Española de Cardiología. Recomendaciones para el uso del tratamiento antitrombótico en cardiología. Rev Esp Cardiol. 1999;52:801-20.
4. Almendral J, Marín E, Medina O, Peinado R, Pérez L, Ruiz R, et al. Guías de práctica clínica de la Sociedad Española de Cardiología en arritmias cardíacas. Rev Esp Cardiol. 2001;54:307-67.
5. Atrial Fibrillation Investigators. Risk factors for stroke and efficiency of antithrombotic therapy in atrial fibrillation, analysis of pooled later from five randomized controlled trials. Arch Intern Med. 1994;154:1449-57.
6. Stroke Prevention in Atrial Fibrillation Investigators. Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: The Stroke Prevention in Atrial Fibrillation study. J Stroke Cerebrovasc Dis. 1995;5:147-57.
7. Go AS, Hylek EM, Phillips KA, Borowsky LH, Henault LE, Chang Y, et al. Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation. 2000;102:11-3.
8. Pearce LA, Hart RG, Halperin JL. Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation. Am J Med. 2000;109:45-51.
9. Hart RG. Warfarin in atrial fibrillation: underused in the elderly, often inappropriately used in the young. Heart. 1999;82:539-40.
10. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864-70.
11. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol. 2000;35:183-7.
12. Petersen P, Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke. 1986;17:622-6.
13. Ruiz Ortiz M, Romo Peñas E, Franco Zapata M, Mesa Rubio D, Anguita Sánchez M, Delgado Ortega M, et al. Anticoagulación oral en la fibrilación auricular no valvular: ¿son efectivas y seguras las recomendaciones científicas en la práctica clínica diaria? Rev Esp Cardiol. 2006;59:688-95.
14. Ruiz Ortiz M, Romo Peñas E, Franco Zapata M, Mesa Rubio D, Anguita Sánchez M, López Granados A, et al. Oral anticoagulation in patients aged 75 years or older with chronic nonvalvular atrial fibrillation: effectiveness and safety in daily clinical practice. Heart. 2005;91:1225-6.
15. Ruiz Ortiz M, Romo Peñas E, Franco Zapata M, Mesa Rubio D, Anguita Sánchez M, López Granados A, et al. Un protocolo prospectivo permite incrementar la utilización de anticoagulación oral en pacientes con fibrilación auricular crónica no valvular. Rev Esp Cardiol. 2003;56:971-7.